Lancet study says benefits of vaccines more than risk of facial paralysisBell's palsy is the sudden onset of one-sided facial paralysis.
CoronaVac vaccine: its results are patchy, but the world can't ignore its usefulnessThe latter, developed by the Sinovac Biotech company, is the latest COVID-19 vaccine to be authorised for emergency use by the World Health...
Indonesia study finds China's Sinovac COVID-19 vaccine highly effective in health workersThe preliminary study was done from data on healthcare workers in the Indonesian capital Jakarta who had received the CoronaVac vaccine bet...
Sinovac COVID-19 vaccine effective but some data lacking - WHO expertsThe assessment came shortly after WHO SAGE experts had voiced "very low confidence" in data provided by Chinese state-owned drugmaker Sinop...
Philippines' Rodrigo Duterte refuses to stop South China Sea patrolsTensions over the sea -- which China claims almost entirely -- have spiked as Beijing refuses to pull out vessels from the Philippines' Exc...
Chinese companies considers mixing vaccines, booster shotsSinovac and Sinopharm, the two Chinese manufacturers that combined have exported hundreds of millions of doses all over the world, say they...
China's Coronavac 80% effective at preventing COVID-19 deaths, say Chile resultsThe results were obtained from a comparison between vaccinated and non-vaccinated people -- a sample size of some 10.5 million in total -- ...
Pakistan approves emergency use of third Chinese COVID-19 vaccine despite low efficacy rateThe Drug Regulatory Authority of Pakistan (DRAP) on Thursday granted Emergency Use Authorisation (EUA) to CoronaVac, developed by Chinese c...
Pakistan approves emergency use of third Chinese COVID vaccine, despite its low efficacy rateCiting officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to ...
Sinovac says its vaccine is safe for children as young as 3There were two instances of high fevers in response to the vaccine during trials, one in a 3-year old participant and the other in a six-ye...
Sinovac vaccine may not trigger sufficient antibody response to Brazil variant, says studyThe emergence of variants of the new coronavirus has raised concern that vaccines and treatments that were developed based on previous stra...
Brazil approves Pfizer Covid vaccine for widespread useHowever, the vaccine is not yet available in Brazil, which is so far using two others: Chinese-developed CoronaVac and one developed by Oxf...
Growing uncertainty over efficacy of China made SinovacThe Sinovac allegedly has shown four different efficacy rates during clinical trials ranging from over 91 to 50 per cent. The global scient...
Explainer: What's behind varying efficacy data for Sinovac's coronavirus vaccine?Researchers in Brazil said it was 50.4% effective at preventing symptomatic infections, barely enough for regulatory approval and below the...
Brazil drug agency questions 'transparency' of China vaccineThe Brazilian health regulator Anvisa on Monday accused China of using criteria that "are not transparent" to win emergency approval of its...
Chinese Covid vaccine candidate appears safe, induces immune response: StudyThe researchers, including those from the Jiangsu Provincial Center for Disease Control and Prevention in China, also found the optimum dos...
Halted Brazil trials of Chinese-made coronavirus vaccine cause surpriseThe potential vaccine is being developed by Chinese biopharmaceutical firm Sinovac and in Brazil would be mostly produced by Sao Paulo's st...